TYK2 inhibitor

OSAKA, Japan and CAMBRIDGE, Mass., March 28, 2026 Takeda announced positive results from its Phase 3 LATITUDE clinical trials...

BEIJING, China — December 23, 2025 — InnoCare Pharma has announced a major clinical development milestone with the approval...